Serveur d'exploration Covid (26 mars)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

[Conventional respiratory support therapy for Severe Acute Respiratory Infections (SARI): Clinical indications and nosocomial infection prevention and control].

Identifieur interne : 000100 ( Main/Exploration ); précédent : 000099; suivant : 000101

[Conventional respiratory support therapy for Severe Acute Respiratory Infections (SARI): Clinical indications and nosocomial infection prevention and control].

Auteurs :

Source :

RBID : pubmed:32164086

Descripteurs français

English descriptors

Abstract

Severe acute respiratory infection (SARI) diseases (such as SARS, MERS, pH1N1) can rapidly progress to acute respiratory failure with high lethality. The outbreak of a novel coronavirus infection can lead to 15%~ 30% patients developing into acute respiratory distress syndrome (ARDS). Respiratory support is the most important therapy for SARI patients with respiratory failure. However, respiratory support is a high skilled technology, which means inappropriate application may bring related complications and cross infection of SARI pathogens among medical staff and non-medical personnel in hospital. Therefore, it is meaningful to established a standardized indication of respiratory support and to prevent related nosocomial transmission in SARI patients.

DOI: 10.3760/cma.j.issn.1001-0939.2020.03.010
PubMed: 32164086


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">[Conventional respiratory support therapy for Severe Acute Respiratory Infections (SARI): Clinical indications and nosocomial infection prevention and control].</title>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32164086</idno>
<idno type="pmid">32164086</idno>
<idno type="doi">10.3760/cma.j.issn.1001-0939.2020.03.010</idno>
<idno type="wicri:Area/PubMed/Corpus">000594</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000594</idno>
<idno type="wicri:Area/PubMed/Curation">000594</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000594</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000095</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000095</idno>
<idno type="wicri:Area/Ncbi/Merge">000F97</idno>
<idno type="wicri:Area/Ncbi/Curation">000F97</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000F97</idno>
<idno type="wicri:Area/Main/Merge">000102</idno>
<idno type="wicri:Area/Main/Curation">000100</idno>
<idno type="wicri:Area/Main/Exploration">000100</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">[Conventional respiratory support therapy for Severe Acute Respiratory Infections (SARI): Clinical indications and nosocomial infection prevention and control].</title>
</analytic>
<series>
<title level="j">Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases</title>
<idno type="ISSN">1001-0939</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Coronavirus Infections (complications)</term>
<term>Cross Infection (prevention & control)</term>
<term>Humans</term>
<term>Pneumonia, Viral (complications)</term>
<term>Respiration, Artificial</term>
<term>Respiratory Distress Syndrome, Adult (therapy)</term>
<term>Respiratory Distress Syndrome, Adult (virology)</term>
<term>Respiratory Insufficiency (therapy)</term>
<term>Respiratory Insufficiency (virology)</term>
<term>Severe Acute Respiratory Syndrome (complications)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Humains</term>
<term>Infection croisée ()</term>
<term>Infections à coronavirus ()</term>
<term>Insuffisance respiratoire ()</term>
<term>Insuffisance respiratoire (virologie)</term>
<term>Pneumopathie virale ()</term>
<term>Syndrome de détresse respiratoire de l'adulte ()</term>
<term>Syndrome de détresse respiratoire de l'adulte (virologie)</term>
<term>Syndrome respiratoire aigu sévère ()</term>
<term>Ventilation artificielle</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Cross Infection</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Respiratory Distress Syndrome, Adult</term>
<term>Respiratory Insufficiency</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Insuffisance respiratoire</term>
<term>Syndrome de détresse respiratoire de l'adulte</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Respiratory Distress Syndrome, Adult</term>
<term>Respiratory Insufficiency</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Humans</term>
<term>Respiration, Artificial</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Humains</term>
<term>Infection croisée</term>
<term>Infections à coronavirus</term>
<term>Insuffisance respiratoire</term>
<term>Pneumopathie virale</term>
<term>Syndrome de détresse respiratoire de l'adulte</term>
<term>Syndrome respiratoire aigu sévère</term>
<term>Ventilation artificielle</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Severe acute respiratory infection (SARI) diseases (such as SARS, MERS, pH1N1) can rapidly progress to acute respiratory failure with high lethality. The outbreak of a novel coronavirus infection can lead to 15%~ 30% patients developing into acute respiratory distress syndrome (ARDS). Respiratory support is the most important therapy for SARI patients with respiratory failure. However, respiratory support is a high skilled technology, which means inappropriate application may bring related complications and cross infection of SARI pathogens among medical staff and non-medical personnel in hospital. Therefore, it is meaningful to established a standardized indication of respiratory support and to prevent related nosocomial transmission in SARI patients.</div>
</front>
</TEI>
<affiliations>
<list></list>
<tree></tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000100 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000100 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32164086
   |texte=   [Conventional respiratory support therapy for Severe Acute Respiratory Infections (SARI): Clinical indications and nosocomial infection prevention and control].
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32164086" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidV2 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021